Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapy.
Daniel J Landsburg, Mitchell E Hughes, Alexa Koike, David Bond, Kami J Maddocks, Ling Guo, Allison M Winter, Brian T Hill, Sarah L Ondrejka, Eric D Hsi, Sunita D Nasta, Jakub Svoboda, Stephen J Schuster, Agata M Bogusz
Author Information
- Daniel J Landsburg: Department of Medicine.
- Mitchell E Hughes: Department of Pharmacy, and. ORCID
- Alexa Koike: Department of Pathology, University of Pennsylvania, Philadelphia, PA.
- David Bond: Department of Internal Medicine and.
- Kami J Maddocks: Department of Internal Medicine and.
- Ling Guo: Department of Pathology, The Ohio State University, Columbus, OH; and.
- Allison M Winter: Department of Hematology/Oncology and.
- Brian T Hill: Department of Hematology/Oncology and.
- Sarah L Ondrejka: Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH.
- Eric D Hsi: Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH.
- Sunita D Nasta: Department of Medicine.
- Jakub Svoboda: Department of Medicine.
- Stephen J Schuster: Department of Medicine.
- Agata M Bogusz: Department of Pathology, University of Pennsylvania, Philadelphia, PA.
No abstract text available.
- Clin Cancer Res. 2012 Nov 15;18(22):6122-35
[PMID: 22966017]
- J Clin Oncol. 2012 Oct 1;30(28):3460-7
[PMID: 22665537]
- Pathol Int. 2008 Sep;58(9):596-600
[PMID: 18801075]
- Nat Med. 2015 Aug;21(8):922-6
[PMID: 26193343]
- J Clin Oncol. 2007 Feb 10;25(5):579-86
[PMID: 17242396]
- Blood. 2016 May 19;127(20):2375-90
[PMID: 26980727]
- Am J Surg Pathol. 2017 Apr;41(4):541-549
[PMID: 28291124]
- Hum Pathol. 2019 Jan;83:124-132
[PMID: 30172916]
- Blood. 2017 Oct 5;130(14):1676-1679
[PMID: 28794071]
- J Clin Oncol. 2012 Oct 1;30(28):3452-9
[PMID: 22851565]
- Ther Adv Hematol. 2018 Apr;9(4):81-87
[PMID: 29623179]
- Blood. 2013 May 16;121(20):4021-31; quiz 4250
[PMID: 23449635]
- PLoS One. 2017 Feb 17;12(2):e0172364
[PMID: 28212447]
- J Clin Oncol. 2017 Jan;35(1):24-31
[PMID: 28034071]
Adenine
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Biomarkers, Tumor
Drug Resistance, Neoplasm
Female
Genes, bcl-2
Genes, myc
Humans
Lymphoma, B-Cell
Male
Middle Aged
Piperidines
Prognosis
Protein Kinase Inhibitors
Pyrazoles
Pyrimidines
Recurrence
Retreatment
Treatment Outcome
Antineoplastic Agents
Biomarkers, Tumor
Piperidines
Protein Kinase Inhibitors
Pyrazoles
Pyrimidines
ibrutinib
Adenine
